Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma Academic Article uri icon

Overview

MeSH Major

  • Melanoma
  • Receptor Protein-Tyrosine Kinases
  • Skin Neoplasms

abstract

  • NLR is a readily available blood test that was independently associated with DOD in patients with high-risk, nonmetastatic melanoma. It is unclear whether high NLR is a passive indicator of poor prognosis or a potential therapeutic target. Further studies to evaluate the prognostic role of NLR to potentially identify those more likely to benefit from adjuvant immunotherapy may prove informative.

publication date

  • March 16, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1245/s10434-017-5836-0

PubMed ID

  • 28303429

Additional Document Info

start page

  • 1

end page

  • 8